Synergistic antiproliferative effect of imatinib and adriamycin in platelet‐derived growth factor receptor‐expressing osteosarcoma cells-Reference-Cited by-同舟云学术

Synergistic antiproliferative effect of imatinib and adriamycin in platelet‐derived growth factor receptor‐expressing osteosarcoma cells

Published:2015-05-26 Issue:7 Volume:106 Page:875-882
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yamaguchi Sayaka I.¹²,Ueki Arisa¹,Sugihara Eiji¹³,Onishi Nobuyuki¹,Yaguchi Tomonori⁴,Kawakami Yutaka⁴,Horiuchi Keisuke²,Morioka Hideo²,Matsumoto Morio²,Nakamura Masaya²,Muto Akihiro⁵,Toyama Yoshiaki²,Saya Hideyuki¹³,Shimizu Takatsune¹³⁵

Affiliation:

1. Division of Gene Regulation Institute for Advanced Medical Research (IAMR) Keio University School of Medicine TokyoJapan

2. Department of Orthopaedic Surgery Keio University School of Medicine TokyoJapan

3. Core research for evolutionary science and technology (CREST) Japan Science and Technology Agency TokyoJapan

4. Division of Cellular Signaling Institute for Advanced Medical Research (IAMR) Keio University School of Medicine TokyoJapan

5. Department of Pathophysiology Hoshi University Tokyo Japan

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Takeda Science Foundation

MEXT-Supported Program for the Strategic Research Foundation at Private Universities

National Institute of Biomedical Innovation of Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12686

Reference33 articles.

1. Current Concepts on the Molecular Biology of Osteosarcoma

2. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

3. Recent advances in osteosarcoma

4. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and validation of a novel NAD⁺ metabolism‐related risk model for prognostic prediction in osteosarcoma;Journal of Orthopaedic Research;2023-12-12

2. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies;MedComm;2023-07-10

3. Targeted therapy for osteosarcoma: a review;Journal of Cancer Research and Clinical Oncology;2023-02-18

4. Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo;Cells;2022-11-15

5. Current Status and Prospects of Targeted Therapy for Osteosarcoma;Cells;2022-11-05